Slow in OTC drug business worsen management hardship.

Published: 2004-06-01 07:00:00

Updated: 2004-06-01 07:00:00

The management performance of the listed drug makers having a fiscal year ended in March was remarkably depressed largely stemming from poor sale performances of the non-prescription drugs.

According to Yakup Press survey, the total sales of those companies during the 2003 fiscal year (from Ap...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK